Gemcitabine/Clofarabine/Busulfan: A New Myeloablative Reduced-Toxicity Conditioning Regimen with High Activity for Allogeneic Stem-Cell Transplant (alloSCT) in Aggressive Lymphomas
作者
Yago L. Nieto,Peter F. Thall,Benigno C. Valdez,Junsheng Ma,Melissa Timmons,Michelle Trapp,Sairah Ahmed,Elizabeth J. Shpall,Roy B. Jones,Chitra M. Hosing,Paolo N. Anderlini,Uday Popat,Muzaffar H. Qazilbash,Amin Majid Alousi,Alison M. Gulbis,Celina Ledesma,Richard E. Champlin,Börje S. Andersson